Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK von Salimi, Azam, Schroeder, Kema Marlen, Schemionek-Reinders, Mirle, Vieri, Margherita, Maletzke, Saskia, Gezer, Deniz, Masouleh, Behzad Kharabi, Appelmann, Iris

Volltext

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia von Maletzke, Saskia, Salimi, Azam, Vieri, Margherita, Schroeder, Kema Marlen, Schemionek, Mirle, Masouleh, Behzad Kharabi, Brümmendorf, Tim H, Koschmieder, Steffen, Appelmann, Iris

Volltext

The Effect of the Proteasome Inhibitor Ixazomib (MLN9708) and UPR Mediated Therapy in Multiple Myeloma Cells and Bone Marrow Niche von Salimi, Azam, Schroeder, Kema Marlen, Vieri, Margherita, Brümmendorf, Tim H., Appelmann, Iris, Kharabi, Behzad

Volltext

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia von Saskia Maletzke, Azam Salimi, Margherita Vieri, Kema Marlen Schroeder, Mirle Schemionek, Behzad Kharabi Masouleh, Tim H. Brümmendorf, Steffen Koschmieder, Iris Appelmann

Volltext